NO312097B1 - Substituerte amidinobenzenderivater og farmasöytiske preparater som omfatter disse - Google Patents

Substituerte amidinobenzenderivater og farmasöytiske preparater som omfatter disse Download PDF

Info

Publication number
NO312097B1
NO312097B1 NO19985572A NO985572A NO312097B1 NO 312097 B1 NO312097 B1 NO 312097B1 NO 19985572 A NO19985572 A NO 19985572A NO 985572 A NO985572 A NO 985572A NO 312097 B1 NO312097 B1 NO 312097B1
Authority
NO
Norway
Prior art keywords
group
compound
oxo
reaction
ethyl
Prior art date
Application number
NO19985572A
Other languages
English (en)
Norwegian (no)
Other versions
NO985572L (no
NO985572D0 (no
Inventor
Yuzo Matsumoto
Seijiro Akamatsu
Masato Ichihara
Tomihisa Kawasaki
Seiji Kaku
Isao Yanagisawa
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO985572D0 publication Critical patent/NO985572D0/no
Publication of NO985572L publication Critical patent/NO985572L/no
Publication of NO312097B1 publication Critical patent/NO312097B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19985572A 1996-05-30 1998-11-27 Substituerte amidinobenzenderivater og farmasöytiske preparater som omfatter disse NO312097B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13727396 1996-05-30
PCT/JP1997/001804 WO1997045413A1 (fr) 1996-05-30 1997-05-28 Derives amidinobenzene substitue et compositions les comportant

Publications (3)

Publication Number Publication Date
NO985572D0 NO985572D0 (no) 1998-11-27
NO985572L NO985572L (no) 1999-01-26
NO312097B1 true NO312097B1 (no) 2002-03-18

Family

ID=15194827

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985572A NO312097B1 (no) 1996-05-30 1998-11-27 Substituerte amidinobenzenderivater og farmasöytiske preparater som omfatter disse

Country Status (18)

Country Link
US (1) US6057324A (fr)
EP (1) EP0905129A4 (fr)
KR (1) KR20000016164A (fr)
CN (1) CN1221405A (fr)
AR (1) AR008374A1 (fr)
AU (1) AU720233B2 (fr)
BR (1) BR9709277A (fr)
CA (1) CA2250038A1 (fr)
CZ (1) CZ389698A3 (fr)
HU (1) HUP9903539A3 (fr)
ID (1) ID16991A (fr)
NO (1) NO312097B1 (fr)
PL (1) PL330204A1 (fr)
RU (1) RU2158263C2 (fr)
SK (1) SK162498A3 (fr)
TW (1) TW403745B (fr)
WO (1) WO1997045413A1 (fr)
ZA (1) ZA974422B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006071958A1 (fr) * 2004-12-29 2006-07-06 Millennium Pharmaceuticals, Inc. Composes utilises comme antagonistes du recepteur de la chimiokine
WO2006071875A1 (fr) 2004-12-29 2006-07-06 Millennium Pharmaceuticals, Inc. Composes utilises comme antagonistes des recepteurs de la chemokine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0542363A3 (en) * 1991-11-14 1993-07-14 Glaxo Group Limited Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
AU4633296A (en) * 1995-02-10 1996-08-27 Yamanouchi Pharmaceutical Co., Ltd. Novel benzamidine derivatives and medicinal composition thereof
JPH0987280A (ja) * 1995-09-28 1997-03-31 Yamanouchi Pharmaceut Co Ltd オキソピペラジン誘導体又はその塩

Also Published As

Publication number Publication date
NO985572L (no) 1999-01-26
RU2158263C2 (ru) 2000-10-27
NO985572D0 (no) 1998-11-27
AU720233B2 (en) 2000-05-25
HUP9903539A2 (hu) 2000-05-28
TW403745B (en) 2000-09-01
AR008374A1 (es) 2000-01-19
WO1997045413A1 (fr) 1997-12-04
EP0905129A1 (fr) 1999-03-31
CA2250038A1 (fr) 1997-12-04
BR9709277A (pt) 1999-08-10
CN1221405A (zh) 1999-06-30
US6057324A (en) 2000-05-02
HUP9903539A3 (en) 2002-01-28
AU2975997A (en) 1998-01-05
PL330204A1 (en) 1999-04-26
ID16991A (id) 1997-11-27
ZA974422B (en) 1997-12-22
KR20000016164A (ko) 2000-03-25
EP0905129A4 (fr) 2000-03-15
CZ389698A3 (cs) 1999-02-17
SK162498A3 (en) 1999-06-11

Similar Documents

Publication Publication Date Title
RU2139851C1 (ru) Ароматическое амидиновое производное и фармацевтическая композиция
EP0288973B1 (fr) Dérivés de benzothiazolinone, leur préparation et composition pharmaceutique
JP2000516252A (ja) 1,4―複素環式メタロプロテアーゼ阻害剤
NZ247765A (en) Heterocyclic substituted hydroxamic acid derivatives; their preparation and medicaments and intermediates therefor
CZ296252B6 (cs) D-Proliny, zpusob jejich výroby a pouzití a lécivo s jejich obsahem
WO2000034255A1 (fr) Thiazoles substitues mettant en oeuvre des modulateurs des selectines p, l et e pour le traitement de maladies humaines
KR100340145B1 (ko) 벤즈아제핀유도체및이의중간체화합물
HU205922B (en) Process for producing thiazol derivatives and pharmaceutical compositions containing them
JPH01186872A (ja) 3,6−ジヒドロ−1,5(2h)−ピリミジンカルボン酸エステル類
US4749703A (en) Calcium antagonist piperazine derivatives, and compositions therefor
NO312097B1 (no) Substituerte amidinobenzenderivater og farmasöytiske preparater som omfatter disse
EP0718290B1 (fr) Dérivés carboxyalcoyle hétérocycliques
CZ20012867A3 (cs) Heterocyklické deriváty jako inhibitory faktoru Xa a farmaceutická kompozice, která je obsahuje
CA2433174A1 (fr) Inhibiteurs de la biosynthese du cholesterol contenant comme principe actif des composes spiro tricycliques
KR20020016942A (ko) 디아조신-디온 유도체 및 이것의 트립타제 억제제로서 용도
MXPA98009568A (en) Derivatives of amidinobenceno substitute and medical compositions of mis
JPH0987280A (ja) オキソピペラジン誘導体又はその塩
WO1996024583A1 (fr) Nouveaux derives de benzamidine et leur composition medicinale
JPH05345765A (ja) ジベンズアゼピン誘導体
JPH06211814A (ja) (チオ)ウレア誘導体
WO2001000613A1 (fr) Composes de benzimidazole et medicaments les contenant
JPS63119442A (ja) アミン化合物
JPS6215547B2 (fr)
JP2002155084A (ja) 3環性複素環化合物、その製造法およびその用途
JPH08333342A (ja) 新規なベンズアミジン誘導体及びその医薬組成物

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2002